BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
301335 Hangzhou Tianyuan Pet Products
- 26.80
- +1.00+3.88%
Market Closed May 15 15:00 CST
3.38BMarket Cap69.43P/E (TTM)
27.87High25.00Low116.34KlotVolume25.86Open25.80Pre Close308.96MTurnover23.33%Turnover Ratio73.42P/E (Static)126.00MShares30.9652wk High1.79P/B1.34BFloat Cap14.9652wk Low30.96Limit Up49.88MShs Float33.71Historical High20.64Limit Down11.12%Amplitude12.90Historical Low0.45Dividend TTM26.56Avg Price52.24KlotAsk1.68%Div YieldTTM100Lot Size58.95KlotBid
Hangzhou Tianyuan Pet Products Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 13.07%569.42M | 35.69%2.76B | 33.10%2.03B | 24.72%1.25B | 17.90%503.6M | 7.96%2.04B | 1.29%1.53B | 16.26%1B | 0.72%427.14M | 1.75%1.89B |
| Operating revenue | 13.07%569.42M | 35.69%2.76B | 33.10%2.03B | 24.72%1.25B | 17.90%503.6M | 7.96%2.04B | 1.29%1.53B | 16.26%1B | 0.72%427.14M | 1.75%1.89B |
| Other operating revenue | ---- | 331.76%57.86M | ---- | 57.08%11.87M | ---- | -49.04%13.4M | ---- | -44.69%7.56M | ---- | -2.46%26.3M |
| Total operating cost | 14.03%556.97M | 38.99%2.7B | 34.72%1.97B | 26.27%1.22B | 18.20%488.45M | 13.10%1.94B | 5.97%1.46B | 20.45%962.92M | 3.33%413.24M | -0.69%1.72B |
| Operating cost | 9.44%458.89M | 38.64%2.32B | 34.45%1.69B | 25.15%1.05B | 17.99%419.3M | 11.03%1.67B | 1.93%1.26B | 19.03%838.28M | 3.28%355.36M | -0.34%1.51B |
| Operating tax surcharges | 24.04%3.31M | 9.21%11.02M | -1.52%7.71M | -13.32%5.12M | -2.47%2.67M | 21.02%10.09M | 16.98%7.83M | 33.03%5.9M | 43.01%2.74M | 17.33%8.34M |
| Operating expense | 47.60%63.33M | 66.85%249.07M | 49.57%176.95M | 51.64%106.82M | 49.34%42.91M | 9.67%149.27M | 19.43%118.31M | 20.04%70.44M | -2.06%28.73M | 18.36%136.11M |
| Administration expense | 28.23%23.31M | 13.54%83.5M | 17.80%60.56M | 24.63%39.84M | 21.93%18.18M | 14.28%73.54M | 7.17%51.41M | 6.29%31.96M | -5.38%14.91M | 13.60%64.35M |
| Financial expense | 267.65%1.48M | -58.27%4.93M | 30.61%9.4M | -80.25%732.61K | -115.86%-884.34K | 166.50%11.82M | 130.27%7.19M | 150.53%3.71M | 17.09%5.58M | -188.69%-17.77M |
| -Interest expense (Financial expense) | ---- | -30.89%14.43M | ---- | -37.35%6.91M | ---- | 93.51%20.88M | ---- | 96.70%11.03M | ---- | 17.40%10.79M |
| -Interest Income (Financial expense) | ---- | 58.41%-6.29M | ---- | 57.93%-4.31M | ---- | -620.21%-15.13M | ---- | -20,197.15%-10.24M | ---- | -1,173.65%-2.1M |
| Research and development | 5.71%6.64M | 28.55%30.8M | 21.25%21.41M | 13.34%14.31M | 6.01%6.28M | 26.55%23.96M | 27.40%17.66M | 35.73%12.63M | 46.25%5.92M | 5.61%18.93M |
| Credit Impairment Loss | 98.38%-47.97K | -230.40%-6.84M | -121.61%-11.21M | -43.66%-8.58M | -124.23%-2.96M | -342.32%-2.07M | -1,016.15%-5.06M | -1,043.03%-5.97M | -318.14%-1.32M | 116.54%854.83K |
| Asset Impairment Loss | -368.65%-1.29M | -283.57%-31.23M | -2,728.51%-4.67M | -255.35%-1.01M | -68.66%478.74K | 10.01%-8.14M | 97.04%-165.05K | 109.65%650.12K | 155.56%1.53M | -136.88%-9.05M |
| Other net revenue | 74.06%3.98M | -454.88%-15.71M | 604.40%2.49M | 149.34%1.95M | 20.89%2.28M | 139.25%4.43M | 96.81%-494.59K | 32.40%-3.96M | 444.44%1.89M | -283.62%-11.28M |
| Fair value change income | -50.83%1.3M | -14.64%4.38M | 23.61%-3.09M | 174.39%5.58M | 240.74%2.64M | 37,760.75%5.13M | 62.75%-4.04M | -28.78%-7.51M | 264.86%773.36K | 100.13%13.55K |
| Invest income | 199.32%3.04M | 1,397.21%10.98M | 519.62%15.95M | -2.71%3.38M | 126.71%1.02M | 93.59%-846.64K | 140.66%2.57M | 447.85%3.47M | -70.63%448.4K | -175.67%-13.21M |
| -Including: Investment income associates | ---- | -514.66%-533.86K | ---- | ---- | ---- | ---86.85K | ---- | ---- | ---- | ---- |
| Asset deal income | ---- | -78.21%14.12K | --14.12K | 198.63%33.19K | 99.70%22.19K | 149.53%64.77K | ---- | --11.11K | --11.11K | --25.96K |
| Other revenue | -10.55%972.81K | -32.11%6.99M | -11.25%5.5M | -52.69%2.55M | 143.00%1.09M | 2.11%10.29M | -19.71%6.2M | -23.87%5.38M | -16.97%447.53K | 22.57%10.08M |
| Operating profit | -5.74%16.43M | -52.24%46.62M | 2.18%67.8M | 3.08%38.59M | 10.40%17.43M | -37.80%97.63M | -41.92%66.36M | -36.05%37.44M | -33.20%15.79M | 20.62%156.94M |
| Add:Non operating Income | ---- | 313.15%27.92K | 312.93%27.88K | 518.48%26.03K | --1.52K | -96.53%6.76K | -96.42%6.75K | -97.60%4.21K | ---- | 447.21%194.77K |
| Less:Non operating expense | -76.62%4.07K | 14.17%289.74K | 61.09%80.59K | -33.13%29.95K | --17.43K | 142.61%253.77K | -4.58%50.03K | 5.44%44.79K | ---- | -71.03%104.6K |
| Total profit | -5.68%16.43M | -52.39%46.36M | 2.16%67.75M | 3.18%38.59M | 10.30%17.41M | -37.99%97.38M | -42.03%66.32M | -36.26%37.4M | -33.65%15.79M | 20.99%157.03M |
| Less:Income tax cost | -51.57%1.99M | -52.94%9.8M | 11.15%15.89M | 10.11%7.68M | 83.21%4.11M | -25.10%20.82M | -27.06%14.3M | -37.57%6.98M | -51.58%2.24M | 22.80%27.8M |
| Net profit | 8.51%14.43M | -52.24%36.56M | -0.31%51.86M | 1.59%30.9M | -1.79%13.3M | -40.76%76.56M | -45.12%52.02M | -35.95%30.42M | -29.31%13.54M | 20.61%129.24M |
| Net profit from continuing operation | 8.51%14.43M | -52.24%36.56M | -0.31%51.86M | 1.59%30.9M | -1.79%13.3M | -40.76%76.56M | -45.12%52.02M | -35.95%30.42M | -29.31%13.54M | 20.61%129.24M |
| Less:Minority Profit | -227.77%-2.18M | -4,426.51%-9.4M | -1,255.45%-2.62M | -89.62%-276.81K | -1,423.52%-666.55K | -134.91%-207.58K | -13.13%-193.04K | 26.59%-145.98K | 10.74%-43.75K | 315.45%594.63K |
| Net profit of parent company owners | 18.97%16.62M | -40.13%45.96M | 4.34%54.47M | 2.01%31.18M | 2.80%13.97M | -40.33%76.77M | -45.02%52.21M | -35.91%30.57M | -29.27%13.59M | 19.75%128.64M |
| Earning per share | ||||||||||
| Basic earning per share | 27.27%0.14 | -39.34%0.37 | 7.32%0.44 | 4.17%0.25 | 0.00%0.11 | -53.79%0.61 | -59.00%0.41 | -52.00%0.24 | -60.71%0.11 | -16.98%1.32 |
| Diluted earning per share | 27.27%0.14 | -39.34%0.37 | 7.32%0.44 | 4.17%0.25 | 0.00%0.11 | -53.79%0.61 | -59.00%0.41 | -52.00%0.24 | -60.71%0.11 | -16.98%1.32 |
| Other composite income | -247.46%-665.74K | 2,446.61%190.93K | -43.44%366.7K | 976.65%721.35K | -50.54%451.46K | -101.25%-8.14K | 968.18%648.3K | -92.68%67K | 173.68%912.8K | 14.55%651.89K |
| Other composite income of parent company owners | -279.10%-651.07K | 984.49%192.28K | -52.74%293.53K | 1,081.51%612.29K | -59.23%363.52K | -103.42%-21.74K | 597.93%621.08K | -94.12%51.82K | 181.97%891.69K | 18.45%635K |
| Other composite income of minority owners | -116.68%-14.67K | -109.95%-1.35K | 168.87%73.17K | 618.58%109.06K | 316.39%87.93K | -19.47%13.6K | 196.18%27.22K | -56.10%15.18K | 22.13%21.12K | -48.79%16.89K |
| Total composite income | 0.11%13.77M | -51.99%36.76M | -0.84%52.23M | 3.73%31.62M | -4.87%13.75M | -41.06%76.55M | -44.47%52.67M | -37.03%30.49M | -25.84%14.46M | 20.58%129.89M |
| Total composite income of parent company owners | 11.41%15.97M | -39.86%46.15M | 3.67%54.77M | 3.84%31.79M | -1.02%14.33M | -40.64%76.75M | -44.41%52.83M | -36.97%30.62M | -25.84%14.48M | 19.74%129.28M |
| Total composite income of minority owners | -280.12%-2.2M | -4,744.63%-9.4M | -1,433.79%-2.54M | -28.24%-167.75K | -2,456.55%-578.62K | -131.72%-193.98K | 16.64%-165.82K | 20.39%-130.81K | 28.65%-22.63K | 351.64%611.52K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.